New Research Poster 2 (open)
New Research Posters Session 2

Thursday, October 23, 2014: 10:00 AM-12:30 PM
 
2.1
A Relationship Between Social Withdrawal (Hikikomori) and Psychopathology in the Korean Adolescent
Tae Young Choi, MD, PhD Catholic University of Daegu, School of Medicine, Daegu South Korea
Jong Hun Lee, MD, PhD Catholic University of Daegu, School of Medicine, Daegu South Korea
Min Jae Seo, MD Daegu Catholic University Medical Center, Daegu South Korea
Yoon Ji Lee, MD Daegu Catholic University Medical Center, Daegu South Korea
Sung Min Choi, MD Daegu Medical Center, Daegu South Korea
 
2.2
Acculturative Family Distancing (AFD) in Secondary School Students: An Examination of Family Cohesion, Ruminations, and Help-Seeking Behaviors in Relation to High Distress
S. Dina Wang-Kraus, BS Stanford University School of Medicine, Stanford, CA
Pooja Loftus, MS Stanford University School of Medicine, Stanford, CA
Isabella Chu, MPH Stanford University School of Medicine, Stanford, CA
Andrés Martin, MD, MPH Stanford University School of Medicine, Stanford, CA
Wei-Chin Hwang, PhD Project Shine and , Stanford, CA
Shashank V. Joshi, MD Stanford University School of Medicine, Stanford, CA
 
2.3
Child Brides in a Syrian Refugee Camp in Turkey: The Lost Generation
Meryem Kutuk Malatya State Hospital, Malatya Turkey
Fatma Celik, BS Malatya State Hospital, Malatya Turkey
Gulay Servi, BS Malatya State Hospital, Malatya Turkey
Mehtap Karali, BS Malatya State Hospital, Malatya Turkey
Gamze Bahsi, BS Malatya State Hospital, Malatya Turkey
Harika Gozukara Bag, MD Inönü University, Malatya Turkey
Ceyhun Servi, MSC Inönü University, Malatya Turkey
Resat Alatli, MSC Inönü University, Malatya Turkey
Betul Kandemir, BS Inönü University, Malatya Turkey
Neslihan Aytekin, BS Inönü University, Malatya Turkey
 
2.4
Losses and Connections: A Qualitative Analysis of Factors Impacting Resilience Among Adolescents in Post-Conflict Liberia
Elizabeth Levey Massachusetts General Hospital, Boston, MA
Christina PC Borba, PhD Massachusetts General Hospital, Boston, MA
Benjamin L. Harris, MD University of Liberia, Monrovia Liberia
Claire E. Oppenheim, BS Massachusetts General Hospital, Boston, MA
Neelam Thakurathi, MD Massachusetts General Hospital, Boston, MA
Alaa Alhomaizi, BA Massachusetts General Hospital, Boston, MA
Naomi S. Plasky, BS Massachusetts General Hospital, Boston, MA
G. Gondah Lekpeh, BS University of Liberia, Monrovia Liberia
Isaac Kekulah, BS University of Liberia, Monrovia Liberia
Jeremiah B. Menyongai Jr. Christ Jubilee, Lowell, MA
Veronique C. Diandy Christ Jubilee, Lowell, MA
Josep N. Varnie II, MS Christ Jubilee, Lowell, MA
Julu Kpor, BA Massachusetts General Hospital, Boston, MA
David C. Henderson, MD Massachusetts General Hospital, Boston, MA
 
2.5
Forms of Disruptive Behavior Disorder: Emotional Responding as a Function of Callous-Unemotional Traits
Soonjo Hwang National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stuart F. White, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Zachary T. Nolan, BA National Institutes of Health and National Institute of Mental Health, Bethesda, MD
Stephen Sinclair, PhD National Institutes of Health and National Institute of Mental Health, Bethesda, MD
James Blair, PhD National Institute of Mental Health, Bethesda, MD
 
2.6
Analysis of Psychopathy in Children With Oppositional Defiant Disorder, Conduct Disorder, and ADHD in China
Jinsong Zhang, MD Xinhua Hospital Affiliated to Shanghai JiaoTong University, School of Medicine, Shanghai China
 
2.7
Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for ADHD
Gregory R. Sayer, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Jennifer Levitt, MD University of California, Los Angeles, Los Angeles, CA
James T. McCracken, MD UCLA Semel Institute for Neuroscience, Los Angeles, CA
 
2.8
Age of Diagnosis Among US High School-Aged Adolescents With ADHD and Its Association With Current Severity, Treatment, and Co-Occurring Conditions, 2011-12
Melissa Danielson, MSPH Centers for Disease Control and Prevention, Atlanta, GA
Susanna Visser, DrPH Centers for Disease Control and Prevention, Atlanta, GA
Joseph Holbrook, PhD Centers for Disease Control and Prevention, Atlanta, GA
Rebecca H. Bitsko, PhD Centers for Disease Control and Prevention, Atlanta, GA
 
2.9
Association of Pyrethroid Pesticide Exposure With ADHD in a Nationally Representative Sample of U.S. Children
Melissa Wagner-Schuman, MD, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Jason R. Richardson, MS, PhD Robert Wood Johnson Medical School and Environmental and Occupational Health Sciences Institute, Piscataway, NJ
Peggy Auinger, MS University of Rochester School of Medicine and Dentistry, Rochester, NY
Joseph M. Braun, MPH, PhD Brown University School of Public Health, Providence, RI
Bruce Lanphear, MD, MPH Simon Fraser University, Vancouver, BC
Kimberly Yolton, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Jeffrey Epstein, PhD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Tanya Froehlich, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
2.10
ADHD With Sluggish Cognitive Tempo is Associated With Internalizing Disorders and Executive Function Deficits in Adults
John E. Leikauf, MD Icahn School of Medicine at Mount Sinai, New York, NY
Mary V. Solanto, PhD Icahn School of Medicine at Mount Sinai, New York, NY
 
2.11
Autism Spectrum Disorder Symptoms in Children With ADHD: A Community-Based Study
Jessica L. Green, BA Murdoch Childrens Research Institute, Parkville Australia
Emma Sciberras, DPsych Murdoch Childrens Research Institute, Parkville Australia
Vicki Anderson, PhD Murdoch Childrens Research Institute, Parkville Australia
Daryl Efron, MD Murdoch Childrens Research Institute, Parkville Australia
Jan Nicholson, PhD Parenting Research Centre, East Melbourne VIC Australia
Nicole Rinehart, PhD Deakin University, Burwood Australia
 
2.12
Challenge, De-Challenge, and Re-Challenge Analysis of Abdominal Pain, Decreased Appetite, and Insomnia in a Study of a Methylphenidate Extended-Release Oral Suspension (MEROS) in Children With ADHD
Donna R. Palumbo, PhD Pfizer Inc., New York, NY
John A. Gillespie, MD, MBA Pfizer Inc., New York, NY
Faith Walters Pfizer Inc., New York, NY
Heidi W Belden Pfizer Inc., New York, NY
Sally A. Berry, MD, PhD Pfizer Inc., New York, NY
 
2.13
Clinical and Executive Differences in ADHD Probands and Their Adolescent Siblings
Pablo A. Mayer, MD Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City Mexico
Lino Palacios, MD, MS Instituto Nacional de Psiquiatría Ramon de la Fuente Muñiz, Mexico City Mexico
Adriana Arias-Caballero National Institute of Psychiatry, Mexico City Mexico
Norma J. Gonzalez, MD Child Psychiatric Hospital, Mexico City Mexico
Francisco De la Peña, MD National Institute of Psychiatry, Mexico City Mexico
Miriam Feria, MD National Institute of Psychiatry, Mexico City Mexico
Rosa E. Ulloa, MD, PhD Child Psychiatric Hospital, Mexico City Mexico
Carlos Cruz, PhD National Institute of Psychiatry, Mexico City Mexico
Patricia Clarck, PhD Hospital Infantil de Mexico , Mexico City Mexico
Carmen Lara, PhD Benemérita Universidad Autónoma de Puebla, Mexico, Puebla Mexico
Corina Benjet, PhD National Institute of Psychiatry, Mexico City Mexico
 
2.14
Common Attention and Executive Functions Impairments in Turner Syndrome and in Children With ADHD
Tamar Green, MD Stanford University, Stanford, CA
Sharon Bade Shrestha, BA Stanford Uiversity, Stanford, CA
Lindsay C. Chromik, MS Stanford University School of Medicine, Stanford, CA
Allan L. Reiss, MD Stanford University School of Medicine, Stanford, CA
 
2.15
Systematic Review and Meta-Analysis of Psychosocial and Behavioral Treatments in Children and Adolescents With Conduct Disorder Problems
Mireille J. Bakker, MSC Radboudumc Nijmegen, Nijmegen Netherlands
Jan K. Buitelaar, MD, PhD Radboud University Medical Center and Karakter Child and Adolescent Psychiatry University Center, Nijmegen Netherlands
Jeffrey C. Glennon, PhD Radboudumc Nijmegen, Nijmegen Netherlands
 
2.16
Theta Burst Stimulation Reveals Deficits in Cortical Plasticity in Youth With Autism Spectrum Disorders
Ernest Pedapati, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Cameron Laue, BS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
David Huddleston, BA Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Atara Minister Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Craig A. Erickson, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Donald L. Gilbert, MD, MS Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Steve Wu, MD Cincinnati Children's Hospital Medical Center, Cincinnati, OH
 
2.18
Risk Behaviors, Depression, and Suicidality in the Rural North Indian Adolescent Population: A Study of Prevalence and Sex Differences
Vedika Nehra, MD Bradely Hospital and Brown University, East Providence, RI
Roshani Vanmali, BA Brown Univeristy, Providence, RI
Anthony Spirito, ABPP, PhD Bradley Hospital and Brown University, East Providence, RI
Jeffrey I. Hunt, MD The Warren Alpert Medical School of Brown University, East Providence, RI
 
2.19
Substance Use and Sexual Risk Behaviors Amongst In-School Youth and Young Adults Living in Liberia
Nicole Quiterio, MD Bay Area Children's Association, San Jose, CA
Benjamin L. Harris, MD University of Liberia, Monrovia Liberia
Christina PC Borba, PhD Massachusetts General Hospital, Boston, MA
David C. Henderson, MD Massachusetts General Hospital, Boston, MA
 
2.21
Measurement of Perception on Traumatic Distress in Korean Children and Adolescents With Sexual Abuse
Eun-Young Shin Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Keun-Ah Cheon, MD, PhD Yonsei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
Seul Bee Lee, MD Severance hospital, Seoul South Korea
Seo Yeon Park, MD Division of Child and Adolescent Psychiatry, Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, South Korea, Seoul South Korea
Hyun-Jin Kim, MD Division of Child and Adolescent Psychiatry, Department of Psychiatry and Institute of Behavioral Science in Medicine, Yonsei University College of Medicine, Seoul, South Korea, Seoul South Korea
Dong-Ho Song, MD, PhD Yosei University College of Medicine, Institute of Behavioral Science in Medicine, Seoul South Korea
 
2.23
Results of AACAP’s Educational Needs Assessment
Anne Glowinski, MD, MPE Washington University School of Medicine, St. Louis, MO
Tristan L. Gorrindo, MD Tristan Gorrindo, MD, Charlestown, MA
 
2.25
Consistency of Effect of Metadoxine Extended Release on Predominantly Inattentive ADHD in Adults
Iris Manor, MD Geha Mental Health Center, Petach Tikva Israel
Jonathan Rubin, MD, MBA Alcobra Inc, Tel Aviv Israel
Lenard Adler, MD New York University School of Medicine, New York, NY
 
2.26
Developing and Testing an Electroencephalography-Based (EEG-Based) Diagnostic Aid for ADHD in Children
Halla Helgadóttir, MSc Mentis Cura, Reykjavík Iceland
Olafur O. Gudmundsson, MD University Hospital, Reykjavik Iceland
Pall Magnusson, MS University Hospital, Reykjavik Iceland
Gisli Baldursson, MD University Hospital, Reykjavik Iceland
Berglind Brynjolfsdottir, MS University Hospital, Reykjavik Iceland
Gudrun Bryndis Gudmundsdottir, MD University Hospital, Reykjavik Iceland
Malfridur Lorange, MS University Hospital, Reykjavik Iceland
Ásdís Emilsdóttir, BS Mentis Cura, Reykjavík Iceland
Nicolas Blin, MS Mentis Cura, Reykjavík Iceland
Gisli Johannesson, PhD Mentis Cura, Reykjavík Iceland
Kristinn Johnsen, PhD Mentis Cura, Reykjavík Iceland
 
2.27
Differential Response Profiles in Children and Adolescents With ADHD: Treatment With Atomoxetine
Linda Wietecha, BSN, MS Eli Lilly and Company, Indianapolis, IN
Shufang Wang, PhD Eli Lilly and Company, Indianapolis, IN
Kathleen A. Day, RN Eli Lilly and Company, Indianapolis, IN
Douglas K. Kelsey, MD Eli Lilly and Company, Indianapolis, IN
Keith Saylor, PhD NeuroScience Inc., Herndon, VA
 
2.28
Emotional Lability in Children With ADHD: Stability and Comparative Effects of Guanfacine, Stimulant, and Combined Treatment
Alexandra Sturm, MA UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
James J. McGough, MD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
Jennifer Cowen, PhD UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA
James T. McCracken, MD UCLA Psychiatry and Biobehavioral Sciences, Los Angeles, CA
 
2.29
Moderators of Comorbidity Between Childhood Asthma and ADHD
Toral Desai University of Virginia, Charlottesville, VA
Leigh C. Gayle, BS University of Virginia Health System, Charlottesville, VA
Doan-Thu Nguyen, MD University of Virginia, Charlottesville, VA
Manan J. Shah, MBBS Calvert Memorial Hospital, Prince Frederick, MD
Vishal Madaan, MD, FAAP University of Virginia Health System, Charlottesville, VA
 
2.30
Metadoxine: A Novel Pharmacological Approach to Treating ADHD With Low Abuse Potential
Johanna Schumann, PhD Alcobra Ltd., Tel Aviv Israel
Jonathan Rubin, MD, MBA Alcobra Inc, Tel Aviv Israel
Yaron Daniely, MBA, PhD Alcobra Ltd., Tel Aviv Israel
Helen L. Rowley, PhD RenaSci Ltd, Nottingham NG1 1GF United Kingdom
Sharon L. Smith, PhD RenaSci Ltd, Nottingham NG1 1GF United Kingdom
Stephen J. Holland, BS RenaSci Ltd, Nottingham NG1 1GF United Kingdom
David J. Heal, PhD RenaSci Ltd, Nottingham NG1 1GF United Kingdom
 
2.31
Maintenance of Response in ADHD: What Do Placebo-Controlled Randomized Withdrawal Studies Tell Us?
Himanshu P. Upadhyaya, MD Eli Lilly and Company, Bellaire, TX
David H. Adams, PhD Eli Lilly and Company, Indianapolis, IN
Yoko Tanaka, PhD Eli Lilly and Company, Indianapolis, IN
Rodrigo Escobar, MD Eli Lilly and Company, Indianapolis, IN
 
2.32
Knowledge/Understanding, Perception, and Attitude Toward ADHD Among Primary School Teachers in Jakarta, Indonesia
Tjhin Wiguna, PhD Cipto Mangunkusumo General Hospital - University of Indonesia, Jakarta Indonesia
Kenny Harsono University of Indonesia, Jakarta Indonesia
 
2.33
Guanfacine Extended Release in Adolescents With ADHD: A Multicenter, Randomized, Placebo-Controlled Trial
Timothy E. Wilens, MD Massachusetts General Hospital, Boston, MA
Linda Harper, MD CNS Healthcare, Orlando, FL
Joel L. Young, MD Rochester Center for Behavioral Medicine, Rochester Hills, MI
Vanja Sikirica, PharmD, MPH Shire, Wayne, PA
Ralph Bloomfield, MSC Shire Pharmaceuticals, Inc., Basingstoke United Kingdom
Andrew Lyne, MSC Shire Pharmaceuticals, Inc., Basingstoke United Kingdom
Gail Rynkowski Shire, Wayne, PA
Brigitte Robertson, MD Shire, Wayne, PA
 
2.35
School Rampage Shootings: How Often Do They Truly Occur?
Deborah Weisbrot, MD Stony Brook University Medical Center, Stony Brook, NY
Gabrielle A. Carlson, MD SUNY at Stony Brook, Stony Brook, NY
 
2.36
The Relationship Between Bullying and Psychological Behavioral Problems Among 4th to 6th Grade Students in Thailand
Jariya Tarugsa, MD Siriraj Hospital, Mahidol University, Thailand, Bangkok Thailand
Niorn Boonpuen, MD Siriraj Hospital, Mahidol University, Thailand, Bangkok Thailand
Napat Sittanomai, MD Siriraj Hospital, Mahidol University, Thailand, Samutprakarn Thailand
 
2.37
Impact of Psychiatry Practice Guidelines on Medication Costs and Youth Aggression in a Residential Juvenile Justice Setting
Terry Git Lee, MD University of Washington, Seattle, WA
Sarah C. Walker, PhD University of Washington, Seattle, WA
Asia S. Bishop, MSW University of Washington, Seattle, WA
Jennifer Redman, MS Juvenile Justice and Rehabilitation Administration, Olympia, WA
Eric Jenkins, BA Juvenile Justice and Rehabilitation Administration, Olympia, WA
 
2.40
Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Stressful Life Events on Aggression in Young Adults
Lu Dong, MA Emory University, Atlanta, GA
Patricia Brennan, PhD Emory University, Atlanta, GA
Constance Hammen, PhD University of California, Los Angeles, Los Angeles, CA
William Bor, PhD University of Queensland, Brisbane Australia
Jake Najman, PhD University of Queensland, Brisbane Australia
Alicia Smith, PhD Emory University, Atlanta, GA
 
2.41
Can Proactive and Reactive Aggression be Distinguished as Different Subtypes of Aggression in Adolescents? A Multi-Level Latent Class Analysis
Kirsten C. Smeets, MSC Karakter Child and Adolescent Psychiatry University Centre Nijmegen, Nijmegen Netherlands
Sanne Oostermeijer, MSC VU University Medical Center Amsterdam, Duivendrecht Netherlands
Martijn Lappenschaar, MD Radboud University Nijmegen, Nijmegen Netherlands
Moran Cohn, MD VU University Medical Center Amsterdam, Duivendrecht Netherlands
Jolanda van der Meer, MSC Radboud University Medical Centre, Nijmegen, Donders Institute for Brain, Cognition and Behaviour, Nijmegen Netherlands
Arne Popma, MD, PhD VU University Medical Center Amsterdam, Duivendrecht Netherlands
Lucres Nauta, PhD VU University Medical Center Amsterdam, Duivendrecht Netherlands
Nanda Rommelse, PhD Radboud University Medical Centre, Nijmegen, Donders Institute for Brain, Cognition and Behaviour, Nijmegen Netherlands
Floortje Scheepers University Medical Center Utrecht and Rudolf Magnus Institute of Neuroscience, Utrecht Netherlands
Jan K. Buitelaar, MD, PhD Radboud University Medical Center and Karakter Child and Adolescent Psychiatry University Center, Nijmegen Netherlands
 
2.42
Evaluating the Impact of Early School-Based Psychiatric Interventions on the Overall Academic Functional Outcomes: A Pilot Study
Ankit A. Parmar, MD Texas Tech University Health Sciences Center, Lubbock, TX
Rashmi Parmar Texas Tech Health Science Center, Lubbock, TX
Deepti S. Vats, MD Texas Tech Health Science Center, Lubbock, TX
Manish Aligeti, MD Texas Tech University Health Sciences Center, Lubbock, TX
Terry McMahon, MD Texas Tech Health Science Center, Lubbock, TX
Billy Philips Jr., MPH, PhD Texas Tech Health Science Center, Lubbock, TX
 
2.44
Multiple Disparities in Quality of ADHD Care Exist for African American Youths
Cynthia A. Fontanella, PhD The Ohio State University Wexner Medical Center, Columbus, OH
Danielle L. Hiance-Steelesmith, MSW The Ohio State University Wexner Medical Center, Columbus, OH
Gary Phillips, MAS The Ohio State University, Columbus, OH
Jeffrey Bridge, PhD The Ohio State University College of Medicine, Columbus, OH
John V. Campo, MD The Ohio State University Wexner Medical Center, Columbus, OH
Jack Stevens, PhD Nationwide Children's Hospital, Columbus, OH
 
2.45
National Patterns in ADHD Diagnosis and Treatment in Youth and Adults
Elisabeth M. Oehrlein, BA University of Maryland, School of Pharmacy, Baltimore, MD
Mehmet Burcu, MS University of Maryland, Baltimore, Baltimore, MD
Daniel Safer, MD University of Maryland School of Medicine, Baltimore, MD
Julie Zito, PhD University of Maryland, Baltimore, MD
 
2.46
Out of the Office and Into the Field: Evaluating Executive Functions and the Efficacy of Methylphenidate on ADHD-Diagnosed Children in an Ecologically Valid Task
Marcos Rosetti Universidad Nacional Autónoma de México, Mexico City Mexico
Homero David Sandoval, MD Hospital Psiquiatrico Infantil Juan N Navarro, Mexico City Mexico
Paola Gutierrez, MD Hospital Psiquiatrico Infantil Juan N Navarro, Mexico City Mexico
Rosa E. Ulloa, MD, PhD Child Psychiatric Hospital, Mexico City Mexico
Robyn Hudson, PhD Universidad Nacional Autónoma de Mexico, Mexico Mexico
 
2.47
Positive Illusions in Youth With ADHD: Is Inflated Actually Inaccurate? Examining the Predictive Accuracy of Academic Self-Evaluations
Todd Chan, BA University of Toronto, Toronto, ON
Rhonda Martinussen, PhD University of Toronto, Toronto, ON
 
2.48
Potential Impact of Drug Dose and Body Weight on Treatment of ADHD Patients With a New Formulation of Methylphenidate Extended-Release Multilayer Beads (MPH-MLR)
Nathan Teuscher, PhD PK/PD Associates, Trophy Club, TX
Akwete Lex Adjei, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Robert Kupper, PhD Rhodes Pharmaceuticals L.P., Coventry, RI
Ann Catherine Childress, MD , Las Vegas, NV
Wei-Wei Chang, PhD NuTec, Inc., Boston, MA
Sharon Wigal AVIDA, Inc., Newport Beach, CA
 
2.49
Predicting Sleep Side Effects Following Methylphenidate Treatment in ADHD Using Machine Learning Approaches
Jae-Won Kim Seoul National University College of Medicine, Seoul South Korea
Vinod Sharma, PhD University of Pittsburgh School of Medicine, Pittsburgh, PA
Dana McMakin University of Pittsburgh, Pittsburgh, PA
Soon-Beom Hong, MD, PhD Seoul National University College of Medicine, Seoul South Korea
Andrew Zalesky, PhD University of Melbourne, Melbourne Australia
Neal D. Ryan, MD University of Pittsburgh Medical Center, Pittsburgh, PA
 
2.50
The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Can Predict Both Better Treatment Response to Methylphenidate and Greater Neuropsychological Improvement in Children With ADHD
Jeong-Hoon Bae, MD, PhD Bongseng Memorial Hospital, Busan South Korea
Bung-Nyun Kim, MD, PhD Seoul National University College of Medicine, Seoul South Korea
Jae-Won Kim Seoul National University College of Medicine, Seoul South Korea
 
2.51
The Relationship Between Behavioral Problems and Parental Stress in Different Subtypes of Untreated Children With ADHD
Yan Li, MS Department of Child and Adolescent Psychiatry, Shanghai China
 
2.52
Theory of Mind in Children With ADHD: The Role of Inhibitory Control and Working Memory
Molly Malone, PhD Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, University of Toronto, Toronto, ON
Jennifer Crosbie, PhD The Hospital for Sick Children, Toronto, ON
Nathan Taback, PhD University of Toronto, Toronto, ON
Russell J. Schachar, MD, FRCP The Hospital for Sick Children, Toronto, ON
Evdokia Anagnostou, MD Holland Bloorview Kids Rehab, Toronto, ON
 
2.53
A Moving Story: Possible Utility of Objective Locomotion Measures in Diagnosing ADHD
Lourdes Garcia Murillo, MD New York University Child Study Center, New York, NY
David Anderson, PhD New York University Child Study Center, New York, NY
Adriana Di Martino, MD The Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, New Yorl University Child Study Center, and New York University Langone Medical Center, New York, NY
F. Xavier Castellanos, MD Nathan Kline Institute for Psychiatric Research, Orangeburg, NY
 
2.54
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Metadoxine Extended Release 1400mg Compared With Placebo Once Daily in 300 Adults With ADHD
Richard Weisler, MD University of North Carolina at Chapel Hill, Raleigh, NC
Lenard Adler, MD New York University School of Medicine, New York, NY
Jonathan Rubin, MD, MBA Alcobra Inc, Plymouth Meeting, PA
Yaron Daniely, MBA, PhD Alcobra Ltd., Tel Aviv Israel
Iris Manor, MD Geha Mental Health Center, Petach Tikva Israel
 
2.55
Gender and ADHD in Ugandan Children: Comparison of Symptoms, Factor Structure, Prevalence, and Executive Functioning
Matthew D. Burkey, MD, MPH The Johns Hopkins University School of Medicine, Baltimore, MD
Sarah McIvor Murray, MPH The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Robert Opoka, MD Makerere University Faculty of Medicine, Kampala Uganda
Michael J. Boivin, MPH, PhD Michigan State University, East Lansing, MI
Judith Bass, MPH, PhD The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
 
2.56
Public Perceptions of Mental Illness and Violence: Data From 7 Trillion Internet Queries, 2004-2014
Matthew D. Burkey, MD, MPH The Johns Hopkins University School of Medicine, Baltimore, MD
Sarah McIvor Murray, MPH The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
Allan M. Andersen, MD Kennedy Krieger Institute, Baltimore, MD
Russell Horwitz, MD, PhD The Johns Hopkins Hospital, Baltimore, MD

See more of: New Research Poster
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.